Meluzio Michael Vincent sold CUE
August 13, 2026 · Form 4 insider transaction
Meluzio Michael Vincent sold 3 shares of Cue Biopharma, Inc. at $31.13 per share, a transaction worth $93.39. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3
Price
$31.13
Total value
$93.39
InsiderMeluzio Michael Vincent
RoleOfficer
CompanyCue Biopharma, Inc. (CUE)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2026
Filing dateAugust 17, 2026
Shares owned after48,961
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.